𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dendritic cells: still a promising tool for cancer immunotherapy

✍ Scribed by L. Aragoneses-Fenoll; A. L. Corbí

Book ID
107596180
Publisher
Springer Milan
Year
2007
Tongue
Spanish
Weight
252 KB
Volume
9
Category
Article
ISSN
1699-048X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lentivirally transduced dendritic cells
Lentivirally transduced dendritic cells as a tool for cancer immunotherapy
✍ Karine Breckpot; Melissa Dullaers; Aude Bonehill; Sonja Van Meirvenne; Carlo Hei 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 348 KB

## Abstract ## Background Dendritic cells (DC) are the professional antigen‐presenting cells of the immune system, fully equipped to prime naive T cells and thus essential components for cancer immunotherapy. ## Methods We tested the influence of several elements (cPPT, trip, WPRE, SIN) on the t

Immunotherapy with dendritic cells for p
Immunotherapy with dendritic cells for prostate cancer
✍ Anna-Katharina Thomas-Kaskel; Cornelius F. Waller; Wolfgang Schultze-Seemann; He 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 152 KB

## Abstract Radical prostatectomy for prostate cancer is followed by PSA recurrence in up to 40% of patients. One third of patients with biochemical relapse progress to uncurable metastatic disease. Therefore, alternative treatment modalities are needed both in the situation of PSA recurrence and i

Exploiting dendritic cells for cancer im
Exploiting dendritic cells for cancer immunotherapy: genetic modification of dendritic cells
✍ Karine Breckpot; Carlo Heirman; Bart Neyns; Kris Thielemans 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 579 KB

## Abstract Dendritic cells (DCs) are pivotal regulators of immune reactivity and immune tolerance. The observation that DCs can recruit naive T cells has invigorated cancer immunology and led to the proposal of DCs as the basis for vaccines designed for the treatment of cancer. Designing effective